Clinical Trial

A Phase I Clinical Trial of JH013 Injection

Name: A Phase I Clinical Trial of JH013 Injection — clinical trial record (NCT06633055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated October 9, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

This is a phase I clinical trial with a single dose escalation to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of JH013 injection in healthy subjects

Trial Details

NCT Number	NCT06633055
Lead Sponsor	Biotech Pharmaceutical Co., Ltd.
Conditions	Healthy Subjects (HS)
Enrollment	32 participants
Start Date	2024-10-31
Primary Completion	2025-06-30 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-10-09